The CDC’s advisory committee is meeting on Thursday and Friday to reconsider some of its fundamental guidelines. -- 📺 Watch NTD News 24/7 on cable, broadcast, and streaming: https://www.ntd.com/watch
Vaccine advisers to the CDC are
considering a major change to the
childhood vaccine schedule. The CDC's
advisory committee is meeting today and
tomorrow to reconsider some of its
fundamental guidelines.
>> Many of you will recall that in
September, ASIP deferred a vote on
proposed changes to the hepatitis B
vaccination schedule. That decision was
not about hesitation or reluctance. It
was about standards.
Several data elements the committee
requested were incomplete and the
evidence did not yet meet the level of
clarity required for a confident
evidence-based recommendation.
>> First, we need to address stakeholder
and parent dissatisfaction that we have
become aware of. Second, we need to
report on the work group's review. More
on that later today. Third, we need to
consider whether there are immunization
policies that are better aligned with
other countries similar to ours, are
based on evidence and support the needs
of high-risisk persons and populations
without treating everyone as if they
were genetically the same, and
explicitly consider public health and
vaccination ethics.
>> The vaccine advisers are a group that
was handpicked by Health and Human
Services Secretary Robert F. Kennedy Jr.
Earlier this year, Kennedy said that
giving the hepatitis B vaccine to
newborns is motivated by money, not
health concerns. The committee is
considering whether to recommend the
birth dose only for babies whose mothers
test positive. For other babies, it will
be up to the parents and their doctors
to decide if a birth dose is
appropriate. The committee is expected
to vote on language that says when a
family decides not to get a birth dose,
then the vaccination series should begin
when the child is 2 months old.
Infection disease experts argue the
vaccine is key to preventing an illness
that's easy to catch and impossible to
cure. They say that delaying the vaccine
for even a few months will drive up vac
in infections and deaths from the
disease.